Distinct haplogenotypes of the dopamine D2 receptor gene are associated with non-smoking behaviour and daily cigarette consumption

Pharmacopsychiatry

Volumn 42, Issue 2, 2009, Pages 41-50

  Wernicke, C ^a   Reese, J ^a   Kraschewski, A ^a   Winterer, G ^b   Rommelspacher, H ^a   Gallinat, J ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; GENOMIC DNA; NICOTINE;

ADULT; ARTICLE; FEMALE; GENE STRUCTURE; GENETIC RISK; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TOBACCO DEPENDENCE; CAUCASIAN; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GERMANY; MIDDLE AGED;

ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, DOPAMINE D2; SMOKING;

EID: 67649227103     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0028-1085444     Document Type: Article

References (60)

1. Albert PR. Heterologous expression of G protein-linked receptors in pituitary and fibroblast cell lines. Vitam Horm 1994 ; 48 : 59-109 [Review]
2. American Cancer Society. Cancer facts and figures Atlanta. GA: American Cancer Society 2004
3. Arinami T, Gao M, Hamaguchi H et al. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997 ; 6 : 577-582
4. Bardel C, Danjean V, G é nin E. ALTree: association detection and localization of susceptibility sites using haplotype phylogenetic trees. Bioinformatics applications note 2006 ; 22 : 1402-1403
5. Barrett JC, Try B, Maller J et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005 ; 21 : 263-265
6. Brody AL, Olmstead RE, London ED et al. Smoking-induced ventral striatum dopamine release. Am J Psychiatry 2004 ; 161 : 1211-1218
7. Carmelli D, Swan GE, Robinette D et al. Genetic influence on smoking-a study of male twins. N Engl J Med 1992 ; 327 : 829-833
8. Center for Disease Control and Prevention. Annual smoking-attributable mortality, years of potentional life cost, and economic costs-United States, 1995-1999. Morbidity and Mortality Weekly Report 2002 ; 51 : 300-303
9. Civelli O, Bunzow JR, Grandy DK. Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol 1993 ; 33 : 281-307 [Review]
10. Corrigall WA, Coen KM, Adamson KL. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 1994 ; 653 : 278-284
11. Chiara G Di. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 2000 ; 393 : 295-314 [Review]
12. Duan J, Wainwright MS, Comeron JM et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003 ; 12 : 205-216
13. Durstewitz D. A few important points about dopamine's role in neural network dynamics. Pharmacopsychiatry 2006 ; 39 (Suppl 1) : S72-S75
14. Finckh U, Rommelspacher H, Kuhn S et al. influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism. Pharmacogenetics 1997 ; 7 : 271-281
15. Gallinat J, Mulert C, Bajbouj M et al. Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage 2002 ; 17 : 110-127
16. Gallinat J, Meisenzahl E, Jacobsen LK et al. Smoking and structural brain deficits: a volumetric MR investigation. Eur J Neurosci 2006 ; 24 : 1744-1750
17. Gallinat J, Lang UE, Jacobsen LK et al. Abnormal hippocampal neurochemistry in smokers: evidence from proton magnetic resonance spectroscopy at 3T. J Clin Psychopharmacol 2007 ; 27 : 80-84
18. Gallinat J, Schubert F. Regional cerebral glutamate concentrations and chronic tobacco consumption. Pharmacopsychiatry 2007 ; 40 : 64-67
19. Gardner EL. Brain reward mechanisms. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, eds. Substance abuse: A Comprehensive Textbook, 4th Ed. Philadelphia: Lippincott Williams and Wilkins 2005 ; 48-97
20. Gelernter J, Yu Y, Weiss R et al. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nico tine dependence in two distinct American populations. Hum Mol Genet 2006 ; 15 : 3498-3507
21. Gingrich JA, Caron MG. Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 1993 ; 16 : 299-321 [Review]
22. Heath AC, Martin NG. Genetic models for the natural history of smoking: evidence for a genetic influence on smoking persistence. Addict Behav 1993 ; 18 : 19-34 [Review]
23. Heatherton TF, Kozlowski LT, Frecker RC et al. The Fagerstr ö m Test for Nicotine Dependence: a revision of the Fagerstr ö m Tolerance Questionnaire . Br J Addict 1991 ; 86 : 1119-1127
24. Hirvonen M, Laakso A, Någren K et al. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 2004 ; 9 : 1060-1051 Erratum in: Mol Psychiatry 2005;10: 889
25. Hwang R, Shinkai T, Luca V De et al. Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations . Psychopharmacology (Berl) 2005 ; 181 : 179-187
26. Ikemoto S, Glazier BS, Murphy JM et al. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J Neurosci 1997 ; 17 : 8580-8587
27. Imperato A, Mulas A, Chiara G Di. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 1986 ; 132 : 337-338
28. Jacobsen LK, Pugh KR, Mencl WE et al. C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. Psychopharmacology (Berl) 2006 ; 188 : 530-540
29. J ö nsson EG, Nöthen MM, Gr ü nhage F et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 1999 ; 4 : 290-296
30. Kendler KS, Neale MC, MacLean CJ et al. Smoking and major depression. A causal analysis. Arch Gen Psychiatry 1993 ; 50 : 36-43
31. Khan ZU, Mrzljak l, Gutierrez A et al. Prominence of the dopamine D2 short isoform in dopaminergic pathways. Proc Natl Acad Sci USA 1998 ; 95 : 7731-7736
32. Kidd KK, Morar B, Castiglione CM et al. A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet 1998 ; 103 : 211-227
33. Kirsch P, Reuter M, Mier D et al. Imaging gene-substance interactions: the effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward. Neurosci Lett 2006 ; 25; 405 : 196-201
34. Laakso A, Pohjalainen T, Bergman J et al. The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal L-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics 2005 ; 15 : 387-391
35. Lang UE, Hellweg R, Gallinat J. Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology 2005 ; 30 : 1148-1153
36. Lang UE, Sander T, Lohoff FW et al. Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl) 2007 ; 190 : 433-439
37. Lerman C, Jepson C, Wileyto EP et al. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology 2006 ; 31 : 231-242
38. Leuner K, M ü ller WE. The complexity of the dopaminergic synapses and their modulation by antipsychotics. Pharmacopsychiatry 2006 ; 39 (Suppl 1) : S15-S20
39. Li MD, Cheng R, Ma JZ et al. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003 ; 98 : 23-31 [Review]
40. Li MD, Ma JZ, Beuten J. Progress in searching for susceptibility loci and genes for smoking-related behaviour. Clin Genet 2004 ; 66 : 382-392 [Review]
41. Lucht MJ, Kuehn KU, Schroeder W et al. influence of the dopamine D2 receptor (DRD2) exon 8 genotype on efficacy of tiapride and clinical outcome of alcohol withdrawal. Pharmacogenetics 2001 ; 11 : 647-653 (Pubitemid 33078233)
42. Luo HR, Hou ZF, Wu J et al. Evolution of the DRD2 gene haplotype and its association with alcoholism in Mexican Americans. Alcohol 2005 ; 36 : 117-125
43. Mercuri NB, Saiardi A, Bonci A et al. Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice. Neuroscience 1997 ; 79 : 323-327
44. Miller SA, Dykes S, Plesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988 ; 16 : 1215
45. Montmayeur JP, Guiramand J, Borelli E. Preferential coupling between dopamine D2 receptors and G-proteins. Mol Endo 1993 ; 163 : 161-170
46. Morton LM, Wang SS, Bergen AW et al. DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Pharmacogenet Genomics 2006 ; 16 : 901-910
47. Nakajima S, Liu X, Lau CL. Synergistic interaction of D1 and D2 dopamine receptors in the modulation of the reinforcing effect of brain stimulation. Behav Neurosci 1993 ; 107 : 161-165
48. Neuhaus A, Bajbouj M, Kienast T et al. Persistent dysfunctional frontal lobe activation in former smokers. Psychopharmacology (Berl) 2006 ; 186 : 191-200
49. Neville MJ, Johnstone EC, Walton RT. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 2004 ; 23 : 540-545
50. Noble EP, Blum K, Ritchie T et al. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991 ; 48 : 648-654
51. Noble EP, Gottschalk LA, Fallon JH et al. D2 dopamine receptor polymorphism and brain regional glucose metabolism. Am J Med Genet 1997 ; 74 : 162-166
52. Noble EP. The DRD2 gene in psychiatric and neurological disorders and its phenotypes. Pharmacogenomics 2000 ; 1 : 309-333 [Review]
53. Pohjalainen T, Rinne JO, Någren K et al. The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 1998 ; 3 : 256-260
54. Pontieri FE, Tanda G, Orzi F et al. effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 1996 ; 382 : 255-257
55. Rein M. Funktionelle Analyse der 3- untranslatierten Region des Dopamin D2 Rezeptor Gens. Dissertationsschrift. Institut f ü r Humangenetik, Universit ä tsklinikum Hamburg Eppendorf 2008
56. Rohde K, F ü rst R. Haplotyping and estimation of haplotype frequencies for closely linked biallelic multilocus genetic phenotypes including nuclear family information. Hum Mutat 2001 ; 17 : 289-295
57. Thompson J, Thomas N, Singleton A et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997 ; 7 : 479-484
58. Usiello A, Baik JH, Rouge-Pont F et al. Distinct functions of the two isoforms of dopamine D2 receptors. Nature 2000 ; 408 : 199-203
59. Wise RA, Gardner EL. Functional anatomy of substance-related disorders . In: D'haenen H, den Boer JA, Willner P, eds. Biological Psychiatry. Wiley, New York 2002 ; 509-522
60. Zhang Y, Bertolino A, Fazio L et al. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci USA 2007 ; 104 : 20552-20557